These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 21198665

  • 21. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P.
    Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
    [Abstract] [Full Text] [Related]

  • 22. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
    Li Y, Subjeck J, Yang G, Repasky E, Wang XY.
    Vaccine; 2006 Jun 19; 24(25):5360-70. PubMed ID: 16714072
    [Abstract] [Full Text] [Related]

  • 23. Gene-based vaccines: recent technical and clinical advances.
    Ulmer JB, Wahren B, Liu MA.
    Trends Mol Med; 2006 May 19; 12(5):216-22. PubMed ID: 16621717
    [Abstract] [Full Text] [Related]

  • 24. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA.
    Curr Opin Mol Ther; 2003 Feb 19; 5(1):10-9. PubMed ID: 12669465
    [Abstract] [Full Text] [Related]

  • 25. Genetic immunization with plasmid DNA mediated by electrotransfer.
    Rochard A, Scherman D, Bigey P.
    Hum Gene Ther; 2011 Jul 19; 22(7):789-98. PubMed ID: 21631165
    [Abstract] [Full Text] [Related]

  • 26. DNA gene fusion vaccines against cancer.
    Zhu D, Stevenson FK.
    Curr Opin Mol Ther; 2002 Feb 19; 4(1):41-8. PubMed ID: 11883694
    [Abstract] [Full Text] [Related]

  • 27. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB, Shearer MH, Kennedy RC.
    J Cell Biochem; 2006 May 15; 98(2):235-42. PubMed ID: 16440328
    [Abstract] [Full Text] [Related]

  • 28. DNA vaccination against tumors.
    Prud'homme GJ.
    J Gene Med; 2005 Jan 15; 7(1):3-17. PubMed ID: 15538731
    [Abstract] [Full Text] [Related]

  • 29. Genetically modified tumour vaccines--where we are today.
    Nawrocki S, Mackiewicz A.
    Cancer Treat Rev; 1999 Feb 15; 25(1):29-46. PubMed ID: 10212588
    [Abstract] [Full Text] [Related]

  • 30. Human clinical trials of plasmid DNA vaccines.
    Liu MA, Ulmer JB.
    Adv Genet; 2005 Feb 15; 55():25-40. PubMed ID: 16291211
    [Abstract] [Full Text] [Related]

  • 31. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P.
    Scand J Immunol; 2009 Feb 15; 69(2):80-9. PubMed ID: 19144076
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma.
    Smorlesi A, Papalini F, Amici A, Orlando F, Pierpaoli S, Mancini C, Provinciali M.
    Vaccine; 2006 Mar 10; 24(11):1766-75. PubMed ID: 16288939
    [Abstract] [Full Text] [Related]

  • 33. Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense.
    Whiteside TL.
    Immunol Invest; 2000 May 10; 29(2):149-62. PubMed ID: 10854184
    [Abstract] [Full Text] [Related]

  • 34. DNA vaccines for emerging infectious diseases: what if?
    Whalen RG.
    Emerg Infect Dis; 1996 May 10; 2(3):168-75. PubMed ID: 8903226
    [Abstract] [Full Text] [Related]

  • 35. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y, Ouyang K, Fang J, Zhang H, Wu G, Ma Y, Zhang Y, Hu X, Jin L, Cao R, Fan H, Li T, Liu J.
    Vaccine; 2009 Aug 27; 27(39):5411-8. PubMed ID: 19616501
    [Abstract] [Full Text] [Related]

  • 36. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
    Vaccine; 2009 Jun 08; 27(28):3692-6. PubMed ID: 19428161
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nucleic acid vaccination strategies against infectious diseases.
    Marć MA, Domínguez-Álvarez E, Gamazo C.
    Expert Opin Drug Deliv; 2015 Jun 08; 12(12):1851-65. PubMed ID: 26365499
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.
    Kraynyak KA, Bodles-Brakhop A, Bagarazzi M.
    Curr Top Microbiol Immunol; 2017 Jun 08; 405():55-78. PubMed ID: 25682101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.